FILE:CELG/CELG-8K-20060420080229.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers	Financial Statements and Exhibits
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
ITEM: Financial Statements and Exhibits
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 19, 2006 CELGENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-16132 22-2711928 - --------------------------------- -------------------------- ------------------- (State or other jurisdiction of (Commission File Number) (IRS Employer incorporation) Identification No.) 86 Morris Avenue, Summit, New Jersey 07901 - ------------------------------------------------------------ ------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (908) 673-9000 - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS. ITEM 5.02(c) ELECTION OF DIRECTOR On April 20, 2006, Celgene Corporation announced the election of Rodman L. Drake to the Company's Board of Directors effective April 19, 2006. Mr. Drake is an experienced corporate director and former CEO with more than 30 years of diverse consulting and executive management experience. He will serve as a member of the Nominating and Audit Committees of the Celgene Board of Directors. Mr. Drake has spent most of his career in executive level positions such as Co-Chairman of KMR Power Company, a developer of independent power projects internationally, Chief Executive Officer and Managing Director of Cresap McCormick and Paget, a leading international management consulting firm, and President of The Mandrake Group, a consulting firm specializing in strategy and organizational design. He is a member of the board of directors of Student Loan Corporation, Jackson Hewitt and Hyperion Funds and several private companies. Mr. Drake received a B.A. degree from Yale University and an M.B.A. from Harvard Business School. Attached hereto and incorporated herein by reference as Exhibit 99.1 is the Press Release announcing the election of Mr. Drake to the Company's Board of Directors. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits 99.1 - Press Release dated April 20, 2006 announcing the election of Rodman L. Drake to the Company's Board of Directors. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELGENE CORPORATION Date: April 20, 2006 By: /s/ Robert J. Hugin ---------------------------------------- Name: Robert J. Hugin Title: Senior Vice President and Chief Financial Officer
EXHIBIT INDEX EXHIBIT NO. DESCRIPTION - ----------- ----------- 99.1 Press release dated April 20, 2006 announcing the election of Rodman L. Drake to the Company's Board of Directors.

Celgene Corporation Elects Rodman L. Drake to Board of Directors SUMMIT, N.J., April 20 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) announced Thursday, April 20, the election of Rodman L. Drake to the Company's Board of Directors. Mr. Drake is an experienced corporate director and former CEO with more than 30 years of diverse consulting and executive management experience. He will serve as a member of the Nominating and Audit Committees of the Celgene Board of Directors. Mr. Drake has spent most of his career in executive level positions such as Co-Chairman of KMR Power Company, a developer of independent power projects internationally, Chief Executive Officer and Managing Director of Cresap McCormick and Paget, a leading international management consulting firm, and President of The Mandrake Group, a consulting firm specializing in strategy and organizational design. Mr. Drake received a B.A. degree from Yale University and an M.B.A. from Harvard Business School. "Celgene will benefit substantially from Rodman's extensive expertise," said John W. Jackson, Chairman and Chief Executive Officer of Celgene Corporation. "He is a welcomed addition to the Board and we look forward to his valuable contributions." About Celgene Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the Company's website at http://www.celgene.com. This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control, which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or other expectations implied by these forward-looking statements. These factors include results of current or pending research and development activities, actions by the FDA and other regulatory authorities, and those factors detailed in the Company's filings with the Securities and Exchange Commission such as 10K, 10Q and 8K reports. SOURCE Celgene Corporation -0- 04/20/2006 /CONTACT: Robert J. Hugin, Senior VP and CFO, +1-908-673-9102, or Brian P. Gill, Senior Director of PR and IR, +1-908-673-9530, both of Celgene Corporation/ /First Call Analyst: / /FCMN Contact: mblackstone@celgene.com / /Web site: http://www.celgene.com / (CELG)


